Paratek Pharmaceuticals Inc (USD)
PRTK
Overview
Key Information
Legal Documents
Financials

Overview

SectorHealthcare
Industry-
Day Range5.01 | 5.35
52-Wk Range- | -
Last Close-
Mkt Cap (m)-
Dividend yield-
ISINUS6993743029
Volume483,749.00
Exchange VenueNAS

Company Profile

Paratek Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on the development and commercialization of therapeutics based upon tetracycline chemistry.

Key Information
Price/Earning-
Price/Book-
Price/Sales-
P/CF-
Rev Growth (3 year avg)729.37
EPS Growth (3 year avg)-
Operating Margin % -698.92
Net Margin %-778.47
Return on Equity-3,247.76
Debt/Equity-

Documents

Prospectus
en 03/07/2019
Annual Report
en 31/12/2019

Please refer to the below issuer website for further documents.

http://www.paratekpharm.com

Financials

Income Statement
USD201420152016201720182019
Revenue (m)4.340.000.0312.6217.1216.54
Operating Income (m)-6.52-70.75-109.83-84.42-104.05-115.63
Net Income (m)-17.84-70.86-111.64-89.07-112.36-128.79
Basic EPS-7.82-4.29-5.51-3.32-3.57-3.93
Avg. Diluted Shares Outstanding (m)2.5316.5020.2526.8331.5132.79
Balance Sheet
USD201420152016201720182019
Current Assets (m)101.33142.42132.10160.49255.24243.35
Non Current Assets (m)8.643.503.633.2144.957.73
Total Assets (m)109.97145.92135.73163.70300.19251.08
Current Liabilities (m)3.7420.5020.4116.7917.7124.20
Total Liabilities (m)------
Total Equity (m)95.22101.2471.5982.4847.58-39.65
Cash Flows
USD201420152016201720182019
Operating Cash Flows (m)-18.53-54.68-94.10-78.57-81.18-134.05
Capital Expenditure (m)--0.86-0.69-1.12-0.06-0.24
Figures are quoted in USD unless stated otherwise
$
5.15
Last Price